Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol + etomidate vs propofol + etomidate for painless gastrointestinal endoscopy
ChiCTR2500107221Phase 4Completed
- Sponsor
- Nanjing Medical University Affiliated Wuxi Second Hospital
- Start
- Aug 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anxiety disorder comparing Ciprofol + etomidate (C-E group) with Propofol + etomidate (P-E group) (2 arms). Primary endpoints: Hemodynamic indicators (blood pressure, heart rate, SpO2) and CFQ frailty scores when OAA/S score ≥4 in recovery room. Started Aug 2025; status: completed.
02
Drugs
ciprofolpropofoletomidate
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500107221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107221.